6 in 10 Austrialians in care take antidepressants … Pneumococcal shot could do double duty to fight viral respiratory infections … Study: Rebounds occurred with both COVID-19 antivirals … Quest stops...
Clinical briefs for Wednesday, Feb. 14
By
Kristen Fischer
Feb 14, 2024
Paxlovid didn’t prevent death in study on older adults with COVID-19 … People with COPD are 8 times more likely to use antibiotics … Remote monitoring tech in care homes lowers hospital admissions...
Report: 1 in 5 will rebound after Paxlovid, but it still works
By
Kristen Fischer
Nov 14, 2023
One in five people who take nirmatrelvir/ritonavir (Paxlovid) get COVID-19 again after the drug clears them of it, according to a new study.
Clinical briefs for Thursday, Nov. 2
By
Kristen Fischer
Nov 02, 2023
Paxlovid didn’t help older adults with long COVID, study shows … What geriatricians should know about monoclonal anti-amyloid antibodies for Alzheimer’s … High salt linked to type 2 diabetes...
COVID-19 antivirals may slightly lower long COVID risk
By
Kristen Fischer
Oct 26, 2023
Even though it may be more pricey for some people to get Paxlovid soon, a new study finds that taking it is linked to a small reduction in long COVID. The same is true for Lagevrio, the other oral drug...
Warning: Paxlovid may interact with other drugs in older adults
By
Kristen Fischer
Oct 24, 2023
Adults who took Paxlovid when they had COVID-19 had a high prevalence of interactions with other drugs, according to a new study. For the most part, the effects of the interactions weren’t too serious...
Paxlovid is about to get more expensive, but not for most older adults
By
Kristen Fischer
Oct 20, 2023
Paxlovid, an oral drug that treats COVID-19, is set to hit the commercial market next month after being managed by the United States federal government since its release. On Wednesday, Pfizer announced...
Certain populations to receive Paxlovid free through 2024, under new agreement
By
Kristen Fischer
Oct 17, 2023
Paxlovid, an oral drug that treats COVID-19, will begin to enter the commercial market starting next month. At the same time, the US federal government is making sure that the country has enough supply,...
Study: Paxlovid lowered COVID hospitalization, death in people more prone to serious disease
By
Kristen Fischer
Oct 03, 2023
As news that COVID-19 activity has declined emerged Monday, a new study was released showing that people vulnerable to severe COVID-19 who took nirmatrelvir and ritonavir (Paxlovid) had a lower risk for...
Paxlovid, Lagevrio lower hospitalization, death risk in people with omicron
By
Kristen Fischer
Sep 22, 2023
People with COVID-19 at risk for severe disease had a lower risk for death and hospitalization if they took nirmatrelvir (Paxlovid) or balapiravir (Lagevrio) compared to no treatment at all, a new study...